Valneva SE

Valneva SE

World Rank (Jan-05-2024)
10,305
Market Cap (Jan-05-2024)
0.731 Billion USD
World Rank (Jul-30-2023)
8,149
Market Cap (Jul-30-2023)
1.127 Billion USD
World Rank (Jan-07-2022)
6,098
Market Cap (Jan-07-2022)
2.096 Billion USD
World Rank (Jan-01-2021)
8,596
Market Cap (Jan-01-2021)
0.858 Billion USD
Company Rank in Country in 2023
Rank in France in July-2023 is 136
Headquarters Country
France
World Region
Europe
World Subregion
Western Europe
Annual Revenue in USD
398 Million USD
Annual Operating Income in USD
-125 Million USD
Annual Net Income in USD
-158 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
685 Million USD
Total Liabilities in USD
442 Million USD
Total Equity in USD
241 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Biotechnology
Company Website
VALNEVA SE
Wikipedia
Wikipedia
Yahoo
Yahoo @ Paris
Company Profile
Valneva SE is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company annual revenue is 110.3 million EUR and total assets are 449 million EUR as on 2020. The headquarters is in France.
Founded Year
2012
Stock Exchange
EURONEXT
Frankfurt

Share